HCA Healthcare, Inc.

NYSE-HCA

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						51,336	51,533	58,752	60,233	64,968	68,347
Total Revenues % Chg.						10%	0.4%	14%	2.5%	7.9%	10.4%
Cost of Goods Sold, Total						32,041	32,243	36,260	37,056	39,389	40,824
Gross Profit						19,295	19,290	22,492	23,177	25,579	27,523
Selling General & Admin Expenses, Total	—	—	—	—	—	855	923	989	976	994	994
Depreciation & Amortization						2,596	2,721	2,853	2,969	3,077	3,172
Other Operating Expenses						8,626	8,384	8,972	10,179	11,881	13,173
Other Operating Expenses, Total						12,077	12,028	12,814	14,124	15,952	17,339
Operating Income						7,218	7,262	9,678	9,053	9,627	10,184
Interest Expense, Total						-1,824	-1,584	-1,566	-1,741	-1,938	-1,992
Net Interest Expenses						-1,824	-1,584	-1,566	-1,741	-1,938	-1,992
Income (Loss) On Equity Invest.						43	54	113	45	22	45
EBT, Excl. Unusual Items						5,437	5,732	8,225	7,357	7,711	8,237
Gain (Loss) On Sale Of Investments	—	—	—		—	—	—	—	—	—	—
Gain (Loss) On Sale Of Assets						18	-7	1,620	1,301	-5	222
Legal Settlements				—	—	—	—	—	—	—	—
Other Unusual Items						-211	-295	-12	-78	—	—
EBT, Incl. Unusual Items						5,244	5,430	9,833	8,580	7,706	8,459
Income Tax Expense						1,099	1,043	2,112	1,746	1,615	1,834
Earnings From Continuing Operations						4,145	4,387	7,721	6,834	6,091	6,625
Minority Interest						-640	-633	-765	-1,191	-849	-887
Net Income						3,505	3,754	6,956	5,643	5,242	5,738
Net Income to Common Incl Extra Items						3,505	3,754	6,956	5,643	5,242	5,738
Net Income to Common Excl. Extra Items						3,505	3,754	6,956	5,643	5,242	5,738
Total Shares Outstanding						338.4	339.4	305.5	277.4	265.5	259.2
Weighted Avg. Shares Outstanding						341.2	338.3	323.3	290.3	272.4	266
Weighted Avg. Shares Outstanding Dil						348.2	343.6	328.8	294.7	276.4	269.6
EPS						10.3	11.1	21.5	19.4	19.2	21.6
EPS Diluted						10.1	10.9	21.2	19.2	19	21.3
EBITDA						9,814	9,983	12,531	12,022	12,704	13,356
Effective Tax Rate						21%	19.2%	21.5%	20.3%	21%	21.7%